STOCK TITAN

Waldencast plc - WALD STOCK NEWS

Welcome to our dedicated page for Waldencast plc news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast plc stock.

Waldencast plc (NASDAQ: WALD) is a global multi-brand beauty and wellness platform focused on developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company operates through two main segments: Obagi Skincare and Milk Makeup.

Obagi Skincare is renowned for its medical-grade skincare products that deliver transformative results. Recently, Obagi announced the appointment of Dr. Suzan Obagi as its first-ever Chief Medical Director. Dr. Obagi is a world-renowned dermatologist and cosmetic surgeon, bringing extensive expertise in aesthetic dermatology and skincare to the company. Under her leadership, Obagi aims to advance its product development, research initiatives, and educational programs. Notable products in the Obagi range include the Obagi Nu-Derm® System, Professional-C®, ELASTIderm®, and Obagi Nu-Cil™, addressing skin concerns like hyperpigmentation, fine lines, hydration, brightening, and acne.

Milk Makeup is another flagship brand under Waldencast, known for its innovative and inclusive beauty products. The brand emphasizes creativity and sustainability, appealing to a diverse range of consumers. Recently, Waldencast appointed Mazdack Rassi, Co-Founder of Milk Makeup, as the Global Brand Director. He will lead the newly formed Creative Council, focusing on future trends in beauty, wellness, and culture.

Waldencast's business model is brand-led, ensuring proximity to customers, agility, and responsiveness in the market while maintaining each brand’s unique identity. The company benefits from the operational scale of a multi-brand platform and the expertise in managing global beauty brands at scale. This approach allows Waldencast to mitigate category fluctuations and achieve asset-light efficiency.

Recent achievements include the launch of the Daily Hydro-Drops® Rejuvenating Eye Gel Cream by Obagi, offering a solution for dry skin around the eyes with 24-hour hydration. Furthermore, Waldencast's financial performance has shown promising growth, with a notable increase in gross profit for Q1 2024 compared to the previous year.

For more information, visit the company’s website: Waldencast Investor Relations.

Rhea-AI Summary
Waldencast plc reports H1’23 Total Net Revenue of $109.3 million, Combined Adjusted EBITDA of $13.9 million, and introduces guidance for the future. The company's Founder and CEO, Michel Brousset, highlighted the strong performance of Milk Makeup with significant revenue growth, while Obagi Skincare faced challenges due to restructuring and delays in Southeast Asia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
-
Rhea-AI Summary
Obagi, a leader in skincare innovation, under Waldencast plc, launches Daily Hydro-Drops® Rejuvenating Eye Gel Cream to target delicate eye skin. The product promises hydration, brightness, and reduced puffiness. Formulated with clinically proven ingredients, it aims to address key skin concerns around the eyes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
none
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) secures continued listing on Nasdaq following a decision by a Nasdaq Hearings Panel. The company must file interim financial statements by April 1, 2024, to maintain compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
Rhea-AI Summary
Waldencast plc appoints Mazdack Rassi as Global Brand Director to lead the newly formed Creative Council, aiming to drive innovation and stay ahead in the beauty and wellness industry. Rassi, along with a team of industry disruptors, will focus on shaping the future of Waldencast by identifying trends and fostering creativity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
-
Rhea-AI Summary
Obagi Cosmeceuticals LLC appoints Dr. Suzan Obagi as Chief Medical Director, a renowned dermatologist and cosmetic surgeon, to drive product development and innovation. Obagi, a subsidiary of Waldencast plc (NASDAQ: WALD), aims to enhance its skincare solutions and maintain its leadership position in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.79%
Tags
none
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) announced its participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit on February 13, 2024. Founder and CEO Michel Brousset will host a fireside chat presentation and meet with investors throughout the day. The presentation will be webcast live and available for replay on the Company’s Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
Rhea-AI Summary
Waldencast plc announced the appointment of Manuel Manfredi as Chief Financial Officer, effective April 1, 2024, replacing Philippe Gautier. Manfredi brings 25 years of experience in the beauty and consumer products industries, with a proven track record at L’Oréal. Founder and CEO, Michel Brousset, expressed confidence in Manfredi's ability to drive financial rigor, growth, and profitability. The outgoing CFO, Philippe Gautier, was credited for strengthening the financial team and internal controls at Waldencast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.36%
Tags
none
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) announced the filing of its annual report for the fiscal year ended December 31, 2022, revealing a net revenue of $92.4 million for the 2022 Successor Period and a net loss of $(120.6) million. The Company had 122,076,410 ordinary shares outstanding as of December 31, 2023, with a Net Debt Position of $176.1 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.29%
Tags
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) received a notice of non-compliance from Nasdaq due to not filing interim financial statements for the period ended June 30, 2023 with the SEC. The company's hearing before the Panel is scheduled for February 8, 2024, where it will present its plan to regain compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none
Rhea-AI Summary
Waldencast plc (WALD) Receives Extension of Stay of Suspension from Nasdaq, Pending Completion of Hearing Process
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
none

FAQ

What is the current stock price of Waldencast plc (WALD)?

The current stock price of Waldencast plc (WALD) is $3.17 as of March 3, 2025.

What is the market cap of Waldencast plc (WALD)?

The market cap of Waldencast plc (WALD) is approximately 411.6M.

What does Waldencast plc do?

Waldencast plc is a global platform for developing, acquiring, accelerating, and scaling conscious, purpose-driven beauty and wellness brands.

What are the main segments of Waldencast plc?

Waldencast operates through two main segments: Obagi Skincare and Milk Makeup.

Who is Dr. Suzan Obagi?

Dr. Suzan Obagi is a world-renowned dermatologist and cosmetic surgeon, recently appointed as the Chief Medical Director of Obagi Skincare.

What is the role of Mazdack Rassi at Waldencast?

Mazdack Rassi, Co-Founder of Milk Makeup, is Waldencast’s Global Brand Director, leading the Creative Council to focus on future trends in beauty, wellness, and culture.

What are some notable products from Obagi Skincare?

Notable products from Obagi Skincare include the Obagi Nu-Derm® System, Professional-C®, ELASTIderm®, and Obagi Nu-Cil™.

What is unique about Milk Makeup?

Milk Makeup is known for its innovative and inclusive beauty products, focusing on creativity and sustainability.

How does Waldencast ensure brand uniqueness?

Waldencast ensures each brand's unique identity through a brand-led business model that maintains proximity to customers, business agility, and market responsiveness.

What recent product did Obagi launch?

Obagi recently launched the Daily Hydro-Drops® Rejuvenating Eye Gel Cream, providing 24-hour hydration for the delicate skin around the eyes.

How has Waldencast's financial performance been recently?

Waldencast reported an increase in gross profit for Q1 2024, showing significant growth compared to the previous year.

Where can I find more information about Waldencast?

More information about Waldencast can be found on their website: https://ir.waldencast.com/.
Waldencast plc

Nasdaq:WALD

WALD Rankings

WALD Stock Data

411.55M
57.18M
59.61%
26.19%
0.24%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
Link
United Kingdom
WHITE PLAINS